Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control

Guo Bin Shan; Rao Y. Surampalli; Rajeshwar D. Tyagi; Tian C. Zhang; Keith C. Lai; Song Yan

doi:10.1061/9780784410301.ch14

Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control

Guo Bin Shan, Rao Y. Surampalli, Rajeshwar D. Tyagi, Tian C. Zhang, Keith C. Lai, Song Yan

Civil Engineering

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English (US)
Title of host publication	Nanotechnologies for Water Environment Applications
Publisher	American Society of Civil Engineers (ASCE)
Pages	444-473
Number of pages	30
ISBN (Electronic)	9780784472774
ISBN (Print)	9780784410301
DOIs	https://doi.org/10.1061/9780784410301.ch14
State	Published - Jan 1 2009

ASJC Scopus subject areas

Engineering(all)
Environmental Science(all)

Access to Document

10.1061/9780784410301.ch14

Cite this

Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control. / Shan, Guo Bin; Surampalli, Rao Y.; Tyagi, Rajeshwar D.; Zhang, Tian C.; Lai, Keith C.; Yan, Song.

Nanotechnologies for Water Environment Applications. American Society of Civil Engineers (ASCE), 2009. p. 444-473.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

@inbook{a4049a4f93c2432fb05f68cb126cd99b,

title = "Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control",

author = "Shan, {Guo Bin} and Surampalli, {Rao Y.} and Tyagi, {Rajeshwar D.} and Zhang, {Tian C.} and Lai, {Keith C.} and Song Yan",

note = "Funding Information: Luck, D., Mikhailidis, D. P., Dashwood, M. R., Barradas, M. A., Sever, P. S., Dandona, €!, and Wakeling, A. (1983). Clin. Endocrinol. Metab. 57,911-914. Luria, R. E. (1975).J. Psychid?: Res. 12,51-57. Maas, J. W. (1975). Arch. Gen. Psychiatry 32, 1357-1361. Maas, J. W., Fawcett, J. A., and Dekirmenjian, H. (1972). Arch. Gen. Psychiatry 26, 252-262. Maas, J. W., Dekirmenjian, H., and Jones, E (1973). In “Frontiers in Catecholamine Re-search” (E. Usdin and S. H. Snyder, eds.), pp. 1091-2096. Pergamon, New York. Maas, J. W., Davis, J.. and Hanin, I. (1982). Psychol. Med. 12,37-43. Maas, J. W., Koslow, S. H., Katz, M. M., Bowden, C. L., Gibbons, R. L., Stokes, l? E., Robins, E., and Davis, J. M. (1984). Am. J. Psychiatry 141, 1159-1171. Mackenzie, T. B., Popkin, M. K., Sheppard, J. E., Stillner, V., Davis, C. M., and Fenimore, D. C. (1980). LancPt 1,322. Maloteaux, J.-M., Gossuin, A., Waterkeyn, C., and Laduron, l? M. (1983). Biochem. Phar- ~ ~ 0321,25. 43-2548. Matussek, N. M.. Ackenheil, M., Hippius, H., Miiller, F., Schroder, H. T., and Wasilewski, B. (1980). Psychzatr Res. 2,25-34. Maxwell, R. A., and White, H. L. (1978). Handb. Psychopharmacol. 14,83-155. Maxwell, R. A., Keenan, P. D., Chaplin, E., Roth, B., and Eckhardt, S. B. (1969). J. P h a m o l . EX^. Ther 166,320-331. Maxwell, R. A,, Chaplin, E., Batmanglidj., Eckhardt, S., Soares, J. R., and Hite, G. (1970a). J. Pharmacof. EX$. T k 173, 158-169. Maxwell, R. A., Eckhardt, S. B., and Hite, G. (1970b).J. Phamacol. Exp. Ther 171,62-69. Maxwell, R. A., Ferris, R. M., Burcsu, J., Woodward, E. C., Tang, D., and Williard, K. (1974).J . Phannacol. Exp. Ther: 191,418-430. Medical Research Council (1965). Clinical trial of the treatment of depressive illness. Report to the Medical Research Council by its clinical psychiatry committee. B?: Med. J. 1, 881-886. Meltzer, H. Y., and Fang, V. S. (1983). Arch. Gen. Psychiatry 40, 501-505. Mendlewicz, J., Pinder, R. M., Stulemeijer, S. M., and Van Porth, R. (1982).J . Affect. DiC. 4,219-226. Meyerson, H. Y., Wennogle, L. P., Abel, M. S., Coupet, J., Lippa, A. S., Dawh, C. E., and Beer, B. (1982). Phnnnncol. Biochem. Behav. 17, 159-163. Mishra, R., Janowsky, A., and Sulser, F. (1979). Eur J. Pharmcol. 60,379-382. Montgomery, S. A. (1982). Adv. Biochem. Psychopharmacol. 31,49-56. Montgomery, S. A., and Asberg, M. (1979). Br J. Psychiatry 134,382-389. Mowery, R. L., and Williams, 0. D. (1979). Clin. Phamcol. Ther 25,717-719. Murphy, D. L., Donellp C., and Moskowitz, J. (1974).A m. J. Psychiatry 131, 1389-1395. Muscettola, G., Galzenati, M., and Balbi, A. (1982). In “Typical and Atypical Antidepres-sants” (E. Costa and G. Racagni, eds.), Vol. 2, pp. 151-156. Raven, New York. Myers, E. D., and Calvert, E. J., (1984). BrJ. Clin. Phnrmacol. 17, 21-25. Nickolson, V. J., and Pinder, R. M. (1984). In ”CRC Handbook of Stereoisomers. Drugs in Psychopharmacology” (D. F. Smith, ed.), pp. 215-240. CRC Press, Boca Raton, Florida. Nielsen, J. L. (1980). Neuropsychobiology 6,52-60. Olpe, H. E. (1982). In “Depression: Molecular and Psychologically Based Therapies-An fntergrative View” u. Korf and L. Pepperlink Huizen, eds.), pp. 21-46. T.G.O. Foundation, Drachten. Olpe, H. R., and Schellenberg, A. (1980). EucJ. Pharmacol. 63,7-13. Ordonez, L. A., and Wurtman, R. J. (1974).A rch. Biochem. Biophys. 160,372-376. Overall, J. E., Hollister, L. E., and Johnson, M. (1966).J. Am. Med. Assoc. 195, 946-948.",

year = "2009",

month = jan,

day = "1",

doi = "10.1061/9780784410301.ch14",

language = "English (US)",

isbn = "9780784410301",

pages = "444--473",

booktitle = "Nanotechnologies for Water Environment Applications",

publisher = "American Society of Civil Engineers (ASCE)",

}

TY - CHAP

T1 - Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control

AU - Shan, Guo Bin

AU - Surampalli, Rao Y.

AU - Tyagi, Rajeshwar D.

AU - Zhang, Tian C.

AU - Lai, Keith C.

AU - Yan, Song

N1 - Funding Information: Luck, D., Mikhailidis, D. P., Dashwood, M. R., Barradas, M. A., Sever, P. S., Dandona, €!, and Wakeling, A. (1983). Clin. Endocrinol. Metab. 57,911-914. Luria, R. E. (1975).J. Psychid?: Res. 12,51-57. Maas, J. W. (1975). Arch. Gen. Psychiatry 32, 1357-1361. Maas, J. W., Fawcett, J. A., and Dekirmenjian, H. (1972). Arch. Gen. Psychiatry 26, 252-262. Maas, J. W., Dekirmenjian, H., and Jones, E (1973). In “Frontiers in Catecholamine Re-search” (E. Usdin and S. H. Snyder, eds.), pp. 1091-2096. Pergamon, New York. Maas, J. W., Davis, J.. and Hanin, I. (1982). Psychol. Med. 12,37-43. Maas, J. W., Koslow, S. H., Katz, M. M., Bowden, C. L., Gibbons, R. L., Stokes, l? E., Robins, E., and Davis, J. M. (1984). Am. J. Psychiatry 141, 1159-1171. Mackenzie, T. B., Popkin, M. K., Sheppard, J. E., Stillner, V., Davis, C. M., and Fenimore, D. C. (1980). LancPt 1,322. Maloteaux, J.-M., Gossuin, A., Waterkeyn, C., and Laduron, l? M. (1983). Biochem. Phar- ~ ~ 0321,25. 43-2548. Matussek, N. M.. Ackenheil, M., Hippius, H., Miiller, F., Schroder, H. T., and Wasilewski, B. (1980). Psychzatr Res. 2,25-34. Maxwell, R. A., and White, H. L. (1978). Handb. Psychopharmacol. 14,83-155. Maxwell, R. A., Keenan, P. D., Chaplin, E., Roth, B., and Eckhardt, S. B. (1969). J. P h a m o l . EX^. Ther 166,320-331. Maxwell, R. A,, Chaplin, E., Batmanglidj., Eckhardt, S., Soares, J. R., and Hite, G. (1970a). J. Pharmacof. EX$. T k 173, 158-169. Maxwell, R. A., Eckhardt, S. B., and Hite, G. (1970b).J. Phamacol. Exp. Ther 171,62-69. Maxwell, R. A., Ferris, R. M., Burcsu, J., Woodward, E. C., Tang, D., and Williard, K. (1974).J . Phannacol. Exp. Ther: 191,418-430. Medical Research Council (1965). Clinical trial of the treatment of depressive illness. Report to the Medical Research Council by its clinical psychiatry committee. B?: Med. J. 1, 881-886. Meltzer, H. Y., and Fang, V. S. (1983). Arch. Gen. Psychiatry 40, 501-505. Mendlewicz, J., Pinder, R. M., Stulemeijer, S. M., and Van Porth, R. (1982).J . Affect. DiC. 4,219-226. Meyerson, H. Y., Wennogle, L. P., Abel, M. S., Coupet, J., Lippa, A. S., Dawh, C. E., and Beer, B. (1982). Phnnnncol. Biochem. Behav. 17, 159-163. Mishra, R., Janowsky, A., and Sulser, F. (1979). Eur J. Pharmcol. 60,379-382. Montgomery, S. A. (1982). Adv. Biochem. Psychopharmacol. 31,49-56. Montgomery, S. A., and Asberg, M. (1979). Br J. Psychiatry 134,382-389. Mowery, R. L., and Williams, 0. D. (1979). Clin. Phamcol. Ther 25,717-719. Murphy, D. L., Donellp C., and Moskowitz, J. (1974).A m. J. Psychiatry 131, 1389-1395. Muscettola, G., Galzenati, M., and Balbi, A. (1982). In “Typical and Atypical Antidepres-sants” (E. Costa and G. Racagni, eds.), Vol. 2, pp. 151-156. Raven, New York. Myers, E. D., and Calvert, E. J., (1984). BrJ. Clin. Phnrmacol. 17, 21-25. Nickolson, V. J., and Pinder, R. M. (1984). In ”CRC Handbook of Stereoisomers. Drugs in Psychopharmacology” (D. F. Smith, ed.), pp. 215-240. CRC Press, Boca Raton, Florida. Nielsen, J. L. (1980). Neuropsychobiology 6,52-60. Olpe, H. E. (1982). In “Depression: Molecular and Psychologically Based Therapies-An fntergrative View” u. Korf and L. Pepperlink Huizen, eds.), pp. 21-46. T.G.O. Foundation, Drachten. Olpe, H. R., and Schellenberg, A. (1980). EucJ. Pharmacol. 63,7-13. Ordonez, L. A., and Wurtman, R. J. (1974).A rch. Biochem. Biophys. 160,372-376. Overall, J. E., Hollister, L. E., and Johnson, M. (1966).J. Am. Med. Assoc. 195, 946-948.

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.scopus.com/inward/record.url?scp=85031027206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031027206&partnerID=8YFLogxK

U2 - 10.1061/9780784410301.ch14

DO - 10.1061/9780784410301.ch14

M3 - Chapter

AN - SCOPUS:85031027206

SN - 9780784410301

SP - 444

EP - 473

BT - Nanotechnologies for Water Environment Applications

PB - American Society of Civil Engineers (ASCE)

ER -

Nanomaterials for environmental burden reduction, waste treatment and non-point source pollution control

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this